Short- and long-term effects of (+)-methamphetamine and (±)-3,4-methylenedioxymethamphetamine on monoamine and corticosterone levels in the neonatal rat following multiple days of treatment

Journal of Neurochemistry

Volumn 104, Issue 6, 2008, Pages 1674-1685

  Schaefer, Tori L ^b   Skelton, Matthew R ^b   Herring, Nicole R ^b   Gudelsky, Gary A ^c   Vorhees, Charles V ^b   Williams, Michael T ^a,b  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

3,4 methylenedioxymethamphetamine; Corticosterone; Development; Dopamine; Methamphetamine; Serotonin

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 HYDROXYINDOLEACETIC ACID; CORTICOSTERONE; DOPAMINE; METHAMPHETAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COGNITIVE DEFECT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOPAMINE BRAIN LEVEL; FEMALE; HIPPOCAMPUS; LEARNING DISORDER; MALE; NEOSTRIATUM; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; SPATIAL DISCRIMINATION;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ANIMALS, NEWBORN; BIOGENIC MONOAMINES; BODY WEIGHT; CORTICOSTERONE; FEMALE; HIPPOCAMPUS; MALE; METHAMPHETAMINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEOSTRIATUM; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 39849100871     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.05112.x     Document Type: Article

References (64)

1. Acevedo S. F., de Esch I. J. P. and Raber J. (2007) Sex- and histaminedependent long-term cognitive effects of methamphetamine exposure. Neuropsychopharmacology 32, 665-672.
2. Aisa B., Tordera R., Lasheras B., Del R. J. and Ramirez M. J. (2007) Cognitive impairment associated to HPA axis hyperactivity after maternal separation in rats. Psychoneuroendocrinology 32, 256-266.
3. Bayer S. L., Altman J., Russo R. J. and Zhang X. (1993) Timetables of Neurogenesis in the Human Brain Based on Experimentally Determined Patterns in the Rat. Neuro Toxicology 14, 83-144.
4. Broening H. W., Bacon L. and Slikker Jr W. (1994) Age modulates the long-term but not the acute effects of the serotonergic neurotoxicant 3,4-methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 271, 285-293.
5. Broening H. W., Morford L. L., Inman-Wood S. L., Fukumura M. and Vorhees C. V. (2001) 3,4-methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development. J. Neurosci. 21, 3228-3235.
6. Brosnan P. G. (2001) The hypothalamic pituitary axis in the fetus and newborn. Semin. Perinatol. 25, 371-384.
7. Buffum J. (1988) Substance abuse and high-risk sexual behavior: drugs and sex-the dark side. J. Psychoactive Drugs 20, 165-168.
8. Cappon G. D., Pu C. and Vorhees C. V. (2000) Time-course of methamphetamine- induced neurotoxicity in rat caudate-putamen after single-dose treatment. Brain Res. 863, 106-111.
9. Cass W. A. (2000) Attenuation and recovery of evoked overflow of striatal serotonin in rats treated with neurotoxic doses of methamphetamine. J. Neurochem. 74, 1079-1085.
10. Cass W. A. and Manning M. W. (1999) Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine 1. J. Neurosci. 19, 7653-7660.
11. Chomchai C., Na M. N., Watanarungsan P., Yossuck P. and Chomchai S. (2004) Methamphetamine abuse during pregnancy and its health impact on neonates born at Siriraj Hospital, Bangkok, Thailand. Southeast Asian J. Trop. Med. Public Health 35, 228-231.
12. Clancy B., Kersh B., Hyde J., Darlington R. B., Anand K. J. S. and Finlay B. L. (2007) Web-based method for translating neurodevelopment from laboratory species to humans. Neuroinformatics. 5, 79-94.
13. Crawford C. A., Williams M. T., Newman E. R., McDougall S. A. and Vorhees C. V. (2003) Methamphetamine exposure during the preweanling period causes prolonged changes in dorsal striatal protein kinase A activity, dopamine D2-like binding sites, and dopamine content. Synapse 48, 131-137.
14. Crawford C. A.,Williams M. T., Kohutek J. L., Choi F. Y., Yoshida S. T., McDougall S. A. and Vorhees C. V. (2006) Neonatal 3,4- methylenedioxymethamphetamine (MDMA) exposure alters neuronal protein kinase A activity, serotonin and dopamine content, and [35S]GTPgammaS binding in adult rats. Brain Res. 1077, 178-186.
15. Degenhardt L. (2005) Drug use and risk behaviour among regular ecstasy users: Does sexuality make a difference? Cult. Health Sex 7, 599-614.
16. EMCDDA (2006) Annual Report 2006: The State of the Drugs Problem in the Europe. European Monitoring Centre for Drugs and Drug Addiction, Luxembourg.
17. Gomes-da-Silva J., de M. R., Fernandez-Ruiz J., Summavielle T. and Tavares M. A. (2004) Effects of neonatal exposure to methamphetamine: catecholamine levels in brain areas of the developing rat. Ann. NY Acad. Sci. 1025, 602-611.
18. Gould E. and Tanapat P. (1999) Stress and hippocampal neurogenesis. Biol. Psychiatry 46, 1472-1479.
19. Gould E., Woolley C. S., Cameron H. A., Daniels D. C. and McEwen B. S. (1991a) Adrenal steroids regulate postnatal development of the rat dentate gyrus: II. Effects of glucocorticoids and mineralocorticoids on cell birth. J. Comp. Neurol. 313, 486-493.
20. Gould E., Woolley C. S. and McEwen B. S. (1991b) Adrenal steroids regulate postnatal development of the rat dentate gyrus: I. Effects of glucocorticoids on cell death. J. Comp. Neurol. 313, 479-485.
21. Herlenius E. and Lagercrantz H. (2004) Development of neurotransmitter systems during critical periods. Exp. Neurol. 190(Suppl. 1), S8-21.
22. Ho E., Karimi-Tabesh L. and Koren G. (2001) Characteristics of pregnant women who use ecstasy (3, 4-methylenedioxymethamphetamine). Neurotoxicol. Teratol. 23, 561-567.
23. Holson R. R. and Pearce B. (1992) Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species. Neurotoxicol. Teratol. 14, 221-228.
24. Johnston L. D. O'Malley P. M. Bachman J. G. and Schulenberg J. E. (2007) Monitoring the Future National Results on Adolescent Drug use: Overview of key Findings, 2006 (NIH Publication No. 07- 6202). National Institute on Drug Abuse, Bethesda.
25. Kirk R. E. (1995) Experimental Design: Procedures for the Behavioral Science. Brooks/Cole Publishing Co., Pacific Grove.
26. Koprich J. B., Campbell N. G. and Lipton J. W. (2003) Neonatal 3,4- methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat. Brain Res. Dev. Brain Res. 147, 177-182.
27. Lauder J. M. (1990) Ontogeny of the serotonergic system in the rat: serotonin as a developmental signal. Ann. NY Acad. Sci. 600, 297-313.
28. Lauder J. M. and Krebs H. (1978) Serotonin as a differentiation signal in early neurogenesis. Dev. Neurosci. 1, 15-30.
29. Liu H., Kaur J., Dashtipour K., Kinyamu R., Ribak C. E. and Friedman L. K. (2003) Suppression of hippocampal neurogenesis is associated with developmental stage, number of perinatal seizure episodes, and glucocorticosteroid level. Exp. Neurol. 184, 196-213.
30. Mazer C., Muneyyirci J., Taheny K., Raio N., Borella A. and Whitaker- Azmitia P. (1997) Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits. Brain Res. 760, 68-73.
31. McCormick C. M., Rioux T., Fisher R., Lang K., MacLaury K. and Teillon S. M. (2001) Effects of neonatal corticosterone treatment on maze performance and HPA axis in juvenile rats. Physiol. Behav. 74, 371-379.
32. McElrath K. (2005) MDMA and sexual behavior: ecstasy users' perceptions about sexuality and sexual risk. Subst. Use Misuse 40, 1461-1477.
33. Meyer J. S., Grande M., Johnson K. and Ali S. F. (2004) Neurotoxic effects of MDMA ("ecstasy") administration to neonatal rats. Int. J. Dev. Neurosci. 22, 261-271.
34. Morford L. L., Inman-Wood S. L., Gudelsky G. A., Williams M. T. and Vorhees C. V. (2002) Impaired spatial and sequential learning in rats treated neonatally with D-fenfluramine. Eur. J. Neurosci. 16, 491-500.
35. Morris R. G., Garrud P., Rawlins J. N. and O'Keefe J. (1982) Place navigation impaired in rats with hippocampal lesions. Nature 297, 681-683.
36. O'Callaghan J. P. and Miller D. B. (2002) Neurotoxic Effects of Substituted Amphetamines in Rats and Mice, in Handbood of Neurotoxicology (Massaro E. J., ed), Vol. 2, pp. 269-301. Humana Press Inc., Totowa.
37. Rawson R. A., Anglin M. D. and Ling W. (2002) Will the methamphetamine problem go away? J. Addict. Dis. 21, 5-19.
38. Rice D. and Barone Jr S. (2000) Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ. Health Perspect. 108(Suppl. 3), 511-533.
39. Sapolsky R. M. and Meaney M. J. (1986) Maturation of the adrenocortical stress response: neuroendocrine control mechanisms and the stress hyporesponsive period. Brain Res. 396, 64-76.
40. Schaefer T. L., Ehrman L. A., Gudelsky G. A., Vorhees C. V. and Williams M. T. (2006) Comparison of monoamine and corticosterone levels 24 h following (+)methamphetamine, (+/))3,4- methylenedioxymethamphetamine, cocaine, (+)fenfluramine or (+/-)methylphenidate administration in the neonatal rat. J. Neurochem. 98, 1369-1378.
41. Schlessinger A. R., Cowan W. M. and Gottlieb D. I. (1975) An autoradiographic study of the time of origin and the pattern of granule cell migration in the dentate gyrus of the rat. J. Comp. Neurol. 159, 149-175.
42. Skelton M. R., Williams M. T. and Vorhees C. V. (2006) Treatment with MDMA from P11-20 disrupts spatial learning and path integration learning in adolescent rats but only spatial learning in older rats. Psychopharmacology (Berl) 189, 307-318.
43. Skelton M. R., Williams M. T., Schaefer T. L. and Vorhees C. V. (2007) Neonatal (+)-methamphetamine increases brain derived neurotrophic factor, but not nerve growth factor, during treatment and results in long-term spatial learning deficits. Psychoneuroendocrinology 32, 734-745.
44. Smith L., Yonekura M. L., Wallace T., Berman N., Kuo J. and Berkowitz C. (2003) Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. J.Dev. Behav. Pediatr. 24, 17-23.
45. Vorhees C. V., Ahrens K. G., Acuff-Smith K. D., Schilling M. A. and Fisher J. E. (1994) Methamphetamine exposure during early postnatal development in rats: II. Hypoactivity and altered responses to pharmacological challenge. Psychopharmacology (Berl) 114, 402-408.
46. Vorhees C. V., Inman-Wood S. L., Morford L. L., Broening H. W., Fukumura M. and Moran M. S. (2000a) Adult learning deficits after neonatal exposure to D-methamphetamine: selective effects on spatial navigation and memory. J. Neurosci. 20, 4732-4739.
47. Vorhees C. V., Inman-Wood S. L., Morford L. L., Reed T. M., Moran M. S., Pu C. and Cappon G. D. (2000b) Evaluation of neonatal exposure to cocaine on learning, activity, startle, scent marking, immobility, and plasma cocaine concentrations. Neurotoxicol. Teratol. 22, 255-265.
48. Vorhees C. V., Reed T. M., Skelton M. R. and Williams M. T. (2004) Exposure to 3,4-methylenedioxymethamphetamine (MDMA) on postnatal days 11-20 induces reference but not working memory deficits in the Morris water maze in rats: implications of prior learning. Int. J. Dev. Neurosci. 22, 247-259.
49. Vorhees C. V., Schaefer T. L. and Williams M. T. (2007) Developmental effects of +/-3,4-methylenedioxymethamphetamine on spatial versus path integration learning: Effects of dose distribution. Synapse 61, 488-499.
50. Wallace T. L., Gudelsky G. A. and Vorhees C. V. (1999) Methamphetamine- induced neurotoxicity alters locomotor activity, stereotypic behavior, and stimulated dopamine release in the rat. J. Neurosci. 19, 9141-9148.
51. Whitaker-Azmitia P. M., Druse M., Walker P. and Lauder J. M. (1996) Serotonin as a developmental signal. Behav. Brain Res. 73, 19-29.
52. Williams M. T., Inman-Wood S. L., Morford L. L., McCrea A. E., Ruttle A. M., Moran M. S., Rock S. L. and Vorhees C. V. (2000) Preweaning treatment with methamphetamine induces increases in both corticosterone and ACTH in rats. Neurotoxicol. Teratol. 22, 751-759.
53. Williams M. T., Vorhees C. V., Boon F., Saber A. J. and Cain D. P. (2002) Methamphetamine exposure from postnatal day 11 to 20 causes impairments in both behavioral strategies and spatial learning in adult rats. Brain Res. 958, 312-321.
54. Williams M. T., Moran M. S. and Vorhees C. V. (2003a) Refining the critical period for methamphetamine-induced spatial deficits in the Morris water maze. Psychopharmacology (Berl) 168, 329-338.
55. Williams M. T., Morford L. L., Wood S. L., Rock S. L., McCrea A. E., Fukumura M., Wallace T. L., Broening H. W., Moran M. S. and Vorhees C. V. (2003b) Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects or injection stress. Brain Res. 968, 89-101.
56. Williams M. T., Morford L. L.,Wood S. L.,Wallace T. L., Fukumura M., Broening H. W. and Vorhees C. V. (2003c) Developmental Dmethamphetamine treatment selectively induces spatial navigation impairments in reference memory in the Morris water maze while sparing working memory. Synapse 48, 138-148.
57. Williams M. T., Brown R. W. and Vorhees C. V. (2004) Neonatal methamphetamine administration induces region-specific longterm neuronal morphological changes in the rat hippocampus, nucleus accumbens and parietal cortex. Eur. J. Neurosci. 19, 3165-3170.
58. Williams M. T., Schaefer T. L., Ehrman L. A., Able J. A., Gudelsky G. A., Sah R. and Vorhees C. V. (2005) 3,4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary-adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity. Brain Res. 1039, 97-107.
59. Williams M. T., Schaefer T. L., Furay A. R., Ehrman L. A. and Vorhees C. V. (2006) Ontogeny of the adrenal response to (+)-methamphetamine in neonatal rats: The effect of prior drug exposure. Stress 9, 153-163.
60. Williams M. T., Herring N. R., Schaefer T. L., Skelton M. R., Campbell N. G., Lipton J. W., McCrea A. E. and Vorhees C. V. (2007) Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine ('foxy') to adult rats: a new drug of abuse. Neuropsychopharmacology 32, 1404-1420.
61. Winer B. J. (1978) Statistics and data analysis: trading bias for reduced mean squared error. Annu. Rev. Psychol. 29, 647-681.
62. Wish E. D., Fitzelle D. B., O'Grady K. E., Hsu M. H. and Arria A. M. (2006) Evidence for significant polydrug use among ecstasy-using college students. J. Am. Coll. Health 55, 99-104.
63. Woolley C. S., Gould E. and McEwen B. S. (1990) Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res. 531, 225-231.
64. Yan W., Wilson C. C. and Haring J. H. (1997) Effects of neonatal serotonin depletion on the development of rat dentate granule cells. Brain Res. Dev. Brain Res. 98, 177-184.